Bone metabolism dysfunction attributed to aging may initiate the loss of bone mass and downregulation of serum sclerostin levels, accelerating the atherosclerosis process in elderly SCAD patients undergoing PCI. The gene discussed is SOST; the disease is atherosclerosis.